Ross Mitgang

PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020.

PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020.

PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020.

PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020.

PsyTech Global is a division of iCAN\: Cannabis that combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The Canadian company is a leader in the development of data-driven tools that allow physicians unprecedented insight into patient well-being and clinical best practices. PsyTech is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. The company also serves as an events platform and innovation scout for psychedelic medicine. Hayim Raclaw has been the CEO of the company since 2020.